Koo....the tweeted article makes specific mention of Resverlogix and includes a link to the company website:

https://ckdnews.com/2017/05/26/ckd-related-cardiovascular-disease-can-be-treated-by-resverlogix-apabetalone/

I'm going to relate a little story that I might have told once before.  A long time back, around the year 2000 I invested in a company called MedTox Scientific because their VP of government marketing graduated from Yale the same year as Dubya. Not everyone finds investments by reading articles touting stocks....personally I think that's a dangerous mine field in all honesty.  

I shared that DD about MedTox on the Yahoo message board for TOX (traded on the AMEX)....My yahoo profile, if clicked on, was directed to a webpage that had a brief bio about me....including my place of employment. Long story longer...my direct line rang a day or two later and it was this same VP of government marketing wanting to know how I'd found out he'd graduated from Yale the same year as Dubya....he thought I was researching MedTox and had discovered it.  Actually I'd found a webpage done by another grad of that class that included the names of those who'd graduated that year and some of the names were hyperlinked to a web page for their work place...Mr. Klaussen, when I clicked on his name it took me to his bio page on MedTox's site, although it made no mention of his graduating from Yale or the year....

Sometimes people work backwards....rather than finding out about a stock and researching it, first they look for companies working on treatments for certain diseases in the biotech space, and then when they find one that is publicly traded they research and do DD.